Literature DB >> 17940287

Selective incorporation of polyanionic molecules into hamster prions.

James C Geoghegan1, Pablo A Valdes, Nicholas R Orem, Nathan R Deleault, R Anthony Williamson, Brent T Harris, Surachai Supattapone.   

Abstract

The central pathogenic event of prion disease is the conformational conversion of a host protein, PrPC, into a pathogenic isoform, PrPSc. We previously showed that the protein misfolding cyclic amplification (PMCA) technique can be used to form infectious prion molecules de novo from purified native PrPC molecules in an autocatalytic process requiring accessory polyanions (Deleault, N. R., Harris, B. T., Rees, J. R., and Supattapone, S. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 9741-9746). Here we investigated the molecular mechanism by which polyanionic molecules facilitate infectious prion formation in vitro. Ina PMCA reaction lacking PrPSc template seed, synthetic polyA RNA molecules induce hamster HaPrPC to adopt a protease-sensitive, detergent-insoluble conformation reactive against antibodies specific for PrPSc. During PMCA, labeled nucleic acids form nuclease-resistant complexes with HaPrP molecules. Strikingly, purified HaPrPC molecules subjected to PMCA selectively incorporate an approximately 1-2.5-kb subset of [32P]polyA RNA molecules from a heterogeneous mixture ranging in size from approximately 0.1 to >6 kb. Neuropathological analysis of scrapie-infected hamsters using the fluorescent dye acridine orange revealed that RNA molecules co-localize with large extracellular HaPrP aggregates. These findings suggest that polyanionic molecules such as RNA may become selectively incorporated into stable complexes with PrP molecules during the formation of native hamster prions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17940287      PMCID: PMC3091164          DOI: 10.1074/jbc.M704447200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  Binding of prion proteins to lipid membranes.

Authors:  Peter Critchley; Jurate Kazlauskaite; Robert Eason; Teresa J T Pinheiro
Journal:  Biochem Biophys Res Commun       Date:  2004-01-16       Impact factor: 3.575

2.  Conformational variations in an infectious protein determine prion strain differences.

Authors:  Motomasa Tanaka; Peter Chien; Nariman Naber; Roger Cooke; Jonathan S Weissman
Journal:  Nature       Date:  2004-03-18       Impact factor: 49.962

Review 3.  A 'unified theory' of prion propagation.

Authors:  C Weissmann
Journal:  Nature       Date:  1991-08-22       Impact factor: 49.962

4.  Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.

Authors:  Gianluca Moroncini; Nnennaya Kanu; Laura Solforosi; Gil Abalos; Glenn C Telling; Mark Head; James Ironside; Jeremy P Brockes; Dennis R Burton; R Anthony Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

5.  Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected].

Authors:  B Caughey; K Brown; G J Raymond; G E Katzenstein; W Thresher
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

6.  Immunolocalization of heparan sulfate proteoglycans to the prion protein amyloid plaques of Gerstmann-Straussler syndrome, Creutzfeldt-Jakob disease and scrapie.

Authors:  A D Snow; T N Wight; D Nochlin; Y Koike; K Kimata; S J DeArmond; S B Prusiner
Journal:  Lab Invest       Date:  1990-11       Impact factor: 5.662

Review 7.  Scrapie strain variation and mutation.

Authors:  M E Bruce
Journal:  Br Med Bull       Date:  1993-10       Impact factor: 4.291

8.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

9.  Protected endogenous retroviral sequences copurify with infectivity in experimental Creutzfeldt-Jakob disease.

Authors:  A Akowitz; E E Manuelidis; L Manuelidis
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Analysis of the interactions between HIV-1 and the cellular prion protein in a human cell line.

Authors:  Pascal Leblanc; Dominique Baas; Jean-Luc Darlix
Journal:  J Mol Biol       Date:  2004-04-02       Impact factor: 5.469

View more
  53 in total

1.  Probing the conformation of a prion protein fibril with hydrogen exchange.

Authors:  Steven M Damo; Aaron H Phillips; Anisa L Young; Sheng Li; Virgil L Woods; David E Wemmer
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

2.  Generation of prions in vitro and the protein-only hypothesis.

Authors:  Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  Prion       Date:  2010-04-05       Impact factor: 3.931

Review 3.  Elucidating the role of cofactors in mammalian prion propagation.

Authors:  Surachai Supattapone
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

4.  Low density subcellular fractions enhance disease-specific prion protein misfolding.

Authors:  James F Graham; Sonya Agarwal; Dominic Kurian; Louise Kirby; Teresa J T Pinheiro; Andrew C Gill
Journal:  J Biol Chem       Date:  2010-01-27       Impact factor: 5.157

Review 5.  Tracking protein aggregate interactions.

Authors:  Christina J Sigurdson; Jason C Bartz; K Peter R Nilsson
Journal:  Prion       Date:  2011-04-01       Impact factor: 3.931

Review 6.  Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions.

Authors:  Byron Caughey; Gerald S Baron; Bruce Chesebro; Martin Jeffrey
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

7.  Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.

Authors:  Samia Hannaoui; Layal Maatouk; Nicolas Privat; Etienne Levavasseur; Baptiste A Faucheux; Stéphane Haïk
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

8.  Prion protein glycosylation is not required for strain-specific neurotropism.

Authors:  Justin R Piro; Brent T Harris; Koren Nishina; Claudio Soto; Rodrigo Morales; Judy R Rees; Surachai Supattapone
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

Review 9.  Cofactor molecules: Essential partners for infectious prions.

Authors:  Surachai Supattapone
Journal:  Prog Mol Biol Transl Sci       Date:  2020-08-24       Impact factor: 3.622

10.  Trans-dominant inhibition of prion propagation in vitro is not mediated by an accessory cofactor.

Authors:  James C Geoghegan; Michael B Miller; Aimee H Kwak; Brent T Harris; Surachai Supattapone
Journal:  PLoS Pathog       Date:  2009-07-31       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.